Neurotech International Ltd

ASX:NTI (Australia)  
A$ 0.05 (-1.92%) Oct 11
At Loss
P/B:
4.16
Market Cap:
A$ 52.77M ($ 35.62M)
Enterprise V:
A$ 41.14M ($ 27.77M)
Volume:
954.25K
Avg Vol (2M):
913.60K
Trade In:
Volume:
954.25K
At Loss
Avg Vol (2M):
913.60K

Business Description

Description
Neurotech International Ltd is a medical device and solutions company conducting clinical studies to assess the neuroprotective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. Geographically, all the firm's business activities function through the region of Australia. It operates in one segment: Medical Device Development and Distribution.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.97
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 91.6
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 15.7
3-Year EPS without NRI Growth Rate 26.3
3-Year Book Growth Rate 26

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 30.91
9-Day RSI 27.77
14-Day RSI 29.94
6-1 Month Momentum % -33.33
12-1 Month Momentum % 27.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 38.77
Quick Ratio 38.77
Cash Ratio 36.9
Days Inventory 349.79
Days Sales Outstanding 77197.5
Days Payable 28044.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.4
Shareholder Yield % -22.08

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -300
Operating Margin % -420150
Net Margin % -253450
FCF Margin % -229750
ROE % -73.62
ROA % -67.31
ROIC % -4279.97
ROC (Joel Greenblatt) % -3278.15
ROCE % -122.05

Financials

ASX:NTI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Neurotech International Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.002
EPS (TTM) (A$) -0.006
Beta 1.39
Volatility % 59.32
14-Day RSI 29.94
14-Day ATR (A$) 0.002512
20-Day SMA (A$) 0.05855
12-1 Month Momentum % 27.27
52-Week Range (A$) 0.048 - 0.125
Shares Outstanding (Mil) 1,034.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neurotech International Ltd Filings

Filing Date Document Date Form
No Filing Data

Neurotech International Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Neurotech International Ltd Frequently Asked Questions

What is Neurotech International Ltd(ASX:NTI)'s stock price today?
The current price of ASX:NTI is A$0.05. The 52 week high of ASX:NTI is A$0.13 and 52 week low is A$0.05.
When is next earnings date of Neurotech International Ltd(ASX:NTI)?
The next earnings date of Neurotech International Ltd(ASX:NTI) is .
Does Neurotech International Ltd(ASX:NTI) pay dividends? If so, how much?
Neurotech International Ltd(ASX:NTI) does not pay dividend.

Press Release

Subject Date
No Press Release